58P Cost-effectiveness analysis of trastuzumab emtansine versus trastuzumab for Chinese patients with residual invasive HER2-positive early breast cancer
Titel:
58P Cost-effectiveness analysis of trastuzumab emtansine versus trastuzumab for Chinese patients with residual invasive HER2-positive early breast cancer
Auteur:
Guan, X. Li, H-C. Chen, Q-J. Hua, B. Li, J-J. Ma, F. Wang, Y-S. Xu, H. Liu, C. Yang, Q. Ma, A-X.